Search filters

Filters
Clear All

Phase

  • 1
  • 6
  • 12
  • 11
  • 2
  • 11
  • 3
  • 32
  • 82
  • 15
  • 3
  • 6
  • 73

Found 82 Uterine Fibroids trials

A listing of Uterine Fibroids medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years - 100 years
All genders
The research study is being conducted to test how providing trauma-informed care training to health care providers and support from a community health worker to patients may affect health outcomes for people with lower kidney functioning, also known as “chronic kidney disease.” Chronic kidney disease can be caused by health …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effectiveness of combining hormone therapy with or without an investigational medication in treating patients with breast cancer. Hormone therapies like tamoxifen citrate and others work by lowering estrogen levels, potentially slowing or stopping cancer growth. The investigational medication being studied may also stop tumor growth by …
18 years or above
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in participants with advanced Pheochromocytoma and Paraganglioma (PCPG). The purpose of this study is to evaluate the response of these tumors to the investigational medication when other treatments are not suitable or have been declined.Participants will undergo a two-stage …
12 years or above
All genders
Phase 1/2
Interventional
This study investigates an investigational medication for patients with advanced non-small cell lung cancer (NSCLC) and other solid tumors that have a specific change in the anaplastic lymphoma kinase (ALK) gene. The purpose of this study is to find out how safe and tolerable the investigational medication is, and to …
18 years or above
All genders
Phase 2
Interventional
This study investigates a maintenance immunotherapy using CD40/Dectin-1 for patients with unresectable pancreatic ductal adenocarcinoma (PDA) who have not shown disease progression after 4-6 months of first-line chemotherapy. This research aims to explore the effectiveness of an investigational immunotherapy in maintaining disease stability in these patients.The study involves several procedures, …
UPCC 15420 Phase I Trial of huCART19-IL18 Cells in Patients with Relapsed or Refractory CD19+ Cancers
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and feasibility of using investigational cells called huCART19-IL18 in patients with relapsed or refractory CD19+ cancers. These are cancers where the CD19 protein is present on the surface of malignant cells, such as certain types of lymphoma and leukemia. The purpose is to determine if …
18 years - 80 years
Female
Phase 1/2
Interventional
This study investigates the safety and effectiveness of an investigational imaging agent in female patients who are undergoing surgery for ductal carcinoma in situ (DCIS) or early-stage breast cancer. The purpose of this study is to understand how the imaging agent works in the body and its potential to aid …
All genders
Observational
This study investigates the use of unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other conditions. The purpose of this study is to understand how well patients recover neutrophil levels, a type of white blood cell important for fighting infections, after …
Immune Health Stability and Plasticity in Healthy Adults
18 years or above
Accepts healthy volunteer
All genders
This is a minimal risk observational study being conducted to evaluate changes in the immune cell populations in the blood, and to learn about the normal fluctuations in these cell populations in adults over time.
30 days or above
All genders
Phase 1/2
Interventional
This study investigates the safety and effectiveness of an investigational medication in patients with relapsed or refractory leukemias, including those with specific genetic changes such as MLL/KMT2A gene rearrangement or NPM1 mutation. The study is divided into two phases: Phase 1 aims to find the best dose of the investigational …